ArticleEye and vision (London, England)2022

PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial.

Farhad Hafezi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.